NEWSROOM

NASDAQ

BranchOut Food Announces Closing of $1.4 Million Follow-On Public Offering

BranchOut Food Announces Closing of $1.4 Million Follow-On Public Offering

Jun 28, 2024

BEND, OR, June 28, 2024 - BranchOut Food Inc. (NASDAQ: BOF), (“BranchOut” or the “Company”), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced the closing of its underwritten public offering of 1,750,000 shares of common stock at a public offering price of $0.80 per share. The gross proceeds from the offering, before underwriting discounts and commissions and estimated offering expenses payable by the Company, are approximately...

BranchOut Food Announces Nation’s Largest Retailer Increases Third Contract to Approximately $1M Annually, Triples Original Commitment

BranchOut Food Announces Nation’s Largest Retailer Increases Third Contract to Approximately $1M Annually, Triples Original Commitment

Jun 27, 2024

New private label dried fruit products expected to enter 3,430 stores in 2024 BEND, Ore., June 27, 2024 -- BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced that the nation’s largest retailer has increased the store count and overall projected sales of its third contract with BranchOut Food. The new third contract now has a value of approximately $1 million in sales and is three times larger...

ANEW MEDICAL Forms Strategic Partnership with Japan’s Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene

ANEW MEDICAL Forms Strategic Partnership with Japan’s Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene

Jun 27, 2024

Collaboration focuses on research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases ANEW’s mission is to deliver transformative protein, cell, and gene therapies in areas of high unmet medical needs, particularly targeting highly prevalent neurodegenerative diseases and age-related disorders NEW YORK, June, 27. 2024 -- ANEW MEDICAL, INC. (Nasdaq: WENA), a biopharmaceutical company specializing in the advancement of novel...

BranchOut Food Prices $1.4 Million Follow-On Public Offering

BranchOut Food Prices $1.4 Million Follow-On Public Offering

Jun 26, 2024

BEND, OR, June 26, 2024 - BranchOut Food Inc. (NASDAQ: BOF) (“BranchOut” or the “Company”), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced the pricing of its underwritten public offering of 1,750,000 shares of common stock at a public offering price of $0.80 per share. The gross proceeds from the offering, before underwriting discounts and commissions and estimated offering expenses payable by the Company, are expected to be...

BranchOut Food Ships First Production of New, Innovative Products to Nation’s Largest Retailer, Initiating Second of Three Existing Contracts Totaling $8M

BranchOut Food Ships First Production of New, Innovative Products to Nation’s Largest Retailer, Initiating Second of Three Existing Contracts Totaling $8M

Jun 26, 2024

BranchOut Food contracts with the retailer now total approximately $8 million in annualized revenue New dried vegetable offerings have shipped ahead of a nationwide launch in July 2024 BEND, Ore., June 26, 2024 -- BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced it has shipped the first production of the new products that will be launched nationwide in July 2024 by the nation’s largest retailer....

ANEW MEDICAL, INC. Secures Key Patent in Europe for HUMAN Klotho Gene RNA Slice Variant and Protein

ANEW MEDICAL, INC. Secures Key Patent in Europe for HUMAN Klotho Gene RNA Slice Variant and Protein

Jun 26, 2024

ANEW to explore therapeutics and specialty diagnostics utilizing the s-KL protein and will pursue other medical product development and commercial opportunities of interest Exclusive, worldwide intellectual property licensed from Universitat Autònoma de Barcelona (UAB) and Institució Catalana de Recerca i Estudis Avançats (ICREA) in Barcelona, Spain NEW YORK, June 26, 2024 - ANEW MEDICAL, INC. (NASDAQ: WENA) (“ANEW” or “the Company”) a biopharmaceutical company specializing in the advancement...

BranchOut Food Ships First Production of New, Innovative Products to Nation’s Largest Retailer, Initiating Second of Three Existing Contracts Totaling $8M

BranchOut Food Enters the $300 Billion Industrial Food Ingredients Market

Jun 25, 2024

Industrial food ingredients expected to be a valuable additional commercialization channel Company to build out internal sales and marketing team to pursue new channel BranchOut Food will showcase its products and services at the ITF Annual Expo in July 2024 BEND, Ore., June 25, 2024 -- BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced that it will enter the industrial food ingredients market as...

SKYX Announces Issuance of 6 Additional Patents in the U.S. and Globally including China, India, Europe, Canada, and Mexico for its Advanced Smart Plug & Play Ceiling Fan & Heater

SKYX Announces Issuance of 6 Additional Patents in the U.S. and Globally including China, India, Europe, Canada, and Mexico for its Advanced Smart Plug & Play Ceiling Fan & Heater

Jun 24, 2024

SKYX’s Enhances its Robust Patent Portfolio Now Totaling over 94 Issued and Pending Patents with over 36 Issued Patents in the U.S. and Globally SKYX’s Robust Patent Portfolio Includes Technologies that Enable and Enhance Performance of Smart Home and AI Sensors, in Addition to Home Safety Sensors Miami, FL, June 24, 2024 – SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 94 issued and pending patents in the US and globally,...

U.S. Army Selects BranchOut Food Products for Field Test with Aim of Revolutionizing MREs

U.S. Army Selects BranchOut Food Products for Field Test with Aim of Revolutionizing MREs

Jun 24, 2024

Cinnamon Churro Banana Bites and Chili Lime Pineapple Chips—Both Made with GentleDry Technology—Excelled in Recent Shelf Life and Sensory Tests BEND, Ore., June 24, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, is taking the next step in its strategic collaboration with the U.S. Army Combat Capabilities Development Command (DEVCOM) to enhance Meals Ready-to-Eat (MRE) through its proprietary...

Oncocyte Appoints Andrea James as Chief Financial Officer

Oncocyte Appoints Andrea James as Chief Financial Officer

Jun 17, 2024

IRVINE, Calif., June 17, 2024 - Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that it has appointed leading finance executive, Andrea James, to the position of Chief Financial Officer. “We are thrilled to welcome Andrea as we approach the inflection point of commercial launch,” Oncocyte CEO Josh Riggs said. “She has a proven track record of guiding financial strategy through multiple phases of growth, raising and stewarding capital, and building...

U.S. Army Selects BranchOut Food Products for Field Test with Aim of Revolutionizing MREs

BranchOut Food Inc. Secures Fourth EnWave Dehydration Machine for New Peru Factory with $40M Production Capacity

Jun 17, 2024

Radiant Energy Vacuum machine will be used in R&D and rapid product development to meet the needs of major retailer demands BEND, Ore., June 17, 2024 -- BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced it has signed a purchase agreement for a 10kW Radiant Energy Vacuum (REV) machine, built by EnWave Corporation (TSX-V: ENW | FSE: E4U). The machine will be installed at BranchOut Food’s new,...

Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte’s VitaGraft Study

Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte’s VitaGraft Study

Jun 3, 2024

New York, June 3, 2024—Oncocyte’s (Nasdaq: OCX) VitaGraft Kidney™ diagnostic test for transplant monitoring has shown promising results in a Phase 2 clinical trial, published in the prestigious New England Journal of Medicine. The trial evaluated the test's effectiveness in monitoring graft health in patients with antibody-mediated rejection (AMR), a leading cause of kidney transplant failure. The study's positive outcomes highlight new clinical uses for VitaGraft Kidney, including therapeutic...

Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus

Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus

May 31, 2024

Clinical testing of LP-310 expected to commence in mid-2024 Patient recruitment is underway for Phase 2a multicenter, dose-ranging study PITTSBURGH, PA., May 31, 2024 -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced the successful completion of its first Site Initiation Visit (SIV) for the Phase 2a trial evaluating LP-310 in the treatment...

AmpliTech Announces Receipt of Notice from Nasdaq Regaining Compliance

AmpliTech Announces Receipt of Notice from Nasdaq Regaining Compliance

May 30, 2024

Hauppauge, NY, May 30, 2024 - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and a global distributor of packages and lids for integrated circuit assembly, announced today that it received a notice from the Nasdaq Stock Market, stating the Company has regained compliance with Nasdaq’s periodic filing...

Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus

Lipella Pharmaceuticals Announces Abstract Publication at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

May 29, 2024

Abstract highlighting new preclinical data from LP-50 in non-muscle invasive bladder cancer PITTSBURGH, Pa., May 29, 2024 – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces an abstract publication at the 2024 American Society of Clinical Oncology (ASCO) annual meeting, taking place from May 31 - June 4 in Chicago, IL, and online. Lipella’s...

U.S. Army Selects BranchOut Food Products for Field Test with Aim of Revolutionizing MREs

BranchOut Food Successfully Completes Key Tests with U.S. Army, Advancing MREs with GentleDry Technology

May 28, 2024

Live troop field tests mark the final phase in integrating GentleDry technology into military rations BEND, Ore., May 28, 2024 -- BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, has completed a successful shelf-life test through a strategic collaboration with the U.S. Army Combat Capabilities Development Command (DEVCOM) to enhance Meals Ready-to-Eat or MREs utilizing BranchOut Food’s proprietary GentleDry...

AmpliTech Announces Receipt of Notice from Nasdaq Regaining Compliance

AmpliTech Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

May 24, 2024

Hauppauge, NY, May 24, 2024 - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), announced today that it received a notice of non-compliance from the Nasdaq Stock Market on May 22, 2024 notifying the company that, as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2024, the company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires listed companies to timely file all periodic...

U.S. Army Selects BranchOut Food Products for Field Test with Aim of Revolutionizing MREs

BranchOut Food Inc. Secures Third EnWave Dehydration Machine; Announces $40M Production Capacity with New Peru Facility

May 24, 2024

BEND, Ore., May 24, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced the expansion of its agreement with EnWave Corporation (TSX-V: ENW | FSE: E4U). As part of this enhanced partnership, BranchOut has purchased its third large-scale EnWave dehydration machine. This addition is strategically aimed at expanding its new facility in Peru, with operations anticipated to commence in Q3,...

Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog

Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog

May 23, 2024

- Record net sales for fiscal year 2024 increased 31% - - Net income increased 127% year over year – -Provides Q1 and Full Fiscal Year 2025 Revenue Guidance – -Backlog Increased to Year-over-Year Record High – -Conference Call Thursday, May 23, 2024 at 9:30am EST – MILTON, NY, May 23, 2024 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for its fourth quarter and fiscal year 2024, ended February 29,...

Following Guidance from U.S. Food & Drug Administration in Type-C Meeting Lipella Pharmaceuticals to Advance Lead Product Candidate to Phase 2b

Following Guidance from U.S. Food & Drug Administration in Type-C Meeting Lipella Pharmaceuticals to Advance Lead Product Candidate to Phase 2b

May 21, 2024

Share: Company to initiate Phase 2b clinical trial in lead asset, LP-10 in 2H 2024 Pittsburgh, PA, May 21, 2024 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company, announced today the receipt of U.S. Food & Drug Administration (“FDA”) Type-C meeting guidance regarding the LP-10 (liposomal tacrolimus) clinical program. Lipella expects to initiate a Phase 2b clinical trial evaluating LP-10 as a treatment for hemorrhagic...

Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog

Sono-Tek Announces Year-End FY 2024 Earnings Conference Call

May 20, 2024

Conference Call on Thursday, May 23, 2024, at 9:30 am ET MILTON, NY, May 20, 2024 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that the Company will hold a conference call to discuss its year-end fiscal year 2024 financial results, ended February 29, 2024, on Thursday, May 23, 2024 at 9:30 am ET. The year-end FY 2024 financial results press release will be issued before the market opens on May 23, 2024. Conference...

Blackboxstocks Files Form S-4 for Evtec Acquisition

Blackboxstocks Files Form S-4 for Evtec Acquisition

May 16, 2024

Reports First Quarter Financial Results for Fintech Operations Dallas, TX, May 16, 2024 – Blackboxstocks Inc. (NASDAQ: BLBX) (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, announced that it filed its Form S-4 on May 13, 2024, for its acquisition of Evtec Aluminium Ltd. and today reported its financial results for the first quarter ended March 31, 2024. The filing of the...

ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

May 15, 2024

Conference Call on Wednesday, May 15, 2024, at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, CA, May 15, 2024 - Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, today reported financial results for the quarter ended March 31, 2024. Recent Highlights Announced global commercialization partnership with Bio-Rad Laboratories, Inc. On track to ship research use only (RUO) GraftAssureTM transplant monitoring test kits to initial customers in Asia, the U.S., and the EU in 2Q 2024. IVD...

BranchOut Food Inc. Announces Record First Quarter 2024 Results, Gross Margin Increased to 19%, On Track for ~$8M Run Rate

BranchOut Food Inc. Announces Record First Quarter 2024 Results, Gross Margin Increased to 19%, On Track for ~$8M Run Rate

May 15, 2024

Achieved a 1,407% revenue increase to $1.47 million in Q1 2024. Increased gross margin to 19% in Q1 2024, up from -3% last year. Secured $8 million in recurring revenue plus $1.1 million in rotational retailer commitments. BEND, Ore., May 15, 2024 - PRISM MediaWire - BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced its recent accomplishments and financial results for the first quarter ended March...

SKYX Reports Record First Quarter Sales of $19.0 Million Compared to $18.6 Million for First Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products

May 14, 2024

MIAMI, FL, May 14, 2024 - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies") (the “Company” or “SKYX”), a highly disruptive platform technology company with over 90 pending and issued patents globally and over 60 lighting and home décor websites, with a mission to make homes and buildings become safe and smart as the new standard, today reported its financial and operational results for the first quarter ended March 31, 2024. First Quarter 2024 and Recent Subsequent Achievements Generated...

BranchOut Food Inc. Announces Record First Quarter 2024 Results, Gross Margin Increased to 19%, On Track for ~$8M Run Rate

BranchOut Food Secures Large Scale Production Facility in Peru Capable of $40M in Production Capacity; Estimated 40-50% Gross Margins

May 14, 2024

Build out to begin immediately, with production expected to commence in the third quarter BEND, Ore., May 14, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced that it has signed a long term lease for a 50,000 square foot production facility in Peru. Under the terms of the agreement, BranchOut Food has the first right to purchase the facility at a fixed price at any point during the...

ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

Oncocyte to Announce First Quarter 2024 Financial Results

May 13, 2024

Conference Call and Webcast on Wednesday, May 15, 2024 at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, CA, May 13, 2024 - Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, announced today that the company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, after U.S. market close. The company will host a conference call and webcast on Wednesday, May 15, 2024, at 4:30 p.m. Eastern Time to discuss its financial results and highlights. Interested parties...

SKYX Announces First Quarter 2024 Corporate Update Call

May 9, 2024

Company to Present First Quarter 2024 Financial Results; Conference Call to be held on Tuesday, May 14 at 4:30 p.m. Eastern Time MIAMI, FL, May 09, 2024 - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive platform technology company with over 90 pending and issued patents globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become safe-advanced and smart as the new standard, announced today that it will host a corporate update...

Potencial de desarrollo de la Industria del Litio

May 7, 2024

New York City, 7 de mayo de 2024 Potencial de desarrollo de la Industria del Litio Obtenga el nuevo informe sin costo El equipo de Vostock Capital ha preparado un informe basado en una encuesta realizada a los +400 participantes en el Congreso Litio America latina 2023, entre los participantes encuestados: personal de los ministerios de minas y energías de América Latina, periodistas de minería, altos ejecutivos de las empresas mineras de Litio, gerentes de las empresas proveedoras de la...

Development Potential of the Lithium Industry

May 7, 2024

New York City, May 07, 2024 Development Potential of the Lithium Industry Get the new report for free The Vostock Capital team has prepared a report based on a survey carried out at the Lithium Latin America 2023 Congress about the development potential of the lithium industry. The survey was conducted among governmental authorities, leading industry companies, mining association presidents, mining journalists, and industry providers, which will cover: LATAM countries with the most favorable...